期刊文献+

用合成线性多肽研究GD小鼠模型的免疫状态 被引量:2

The immune responses in Graves' disease mouse model as investigated through synthetic linear peptides
原文传递
导出
摘要 用合成的线性多肽探讨Graves病(Graves disease,GD)小鼠模型的免疫状态。用表达促甲状腺素受体(TSHR)A亚单位的腺病毒(A-TSHR-Ad)免疫BALB/c雌性小鼠获得GD小鼠模型;用合成的TSHR A亚单位的线性多肽PA,刺激小鼠脾脏细胞,检测记忆性淋巴细胞反应中生成的细胞因子。所有接受免疫的小鼠均出现TRAb增高,66.7%的小鼠出现甲亢;接受免疫的小鼠脾脏细胞在接受多肽刺激后,IFN-γ生成增加(PPA-2=0.01),IL-4的生成则未受影响。表明T细胞可以识别TSHR A亚单位的线性多肽PA,多肽PA可以促进GD小鼠Th1免疫应答的发生。 To investigate the immune responses in Graves disease(GD) mouse model with synthetic linear peptides,the female BALB/c mice were immunized with adenovirus expressing the A subunit of TSH receptor(TSHR)(A-TSHR-Ad),thus producing the GD mouse model.The splenocytes of this mouse model were stimulated with synthetic linear peptides,and the cytokines produced in the culture supernatants of the stimulated memory lymphocytes were assayed.It was found that all the immunized mice showed an elevated level of TRAb wi...
出处 《现代免疫学》 CAS CSCD 北大核心 2009年第1期55-58,共4页 Current Immunology
基金 上海市重点(优势)学科资助项目(Y0204) 上海市卫生局科研基金资助项目(044054)
关键词 GRAVES病 小鼠模型 线性多肽 Γ干扰素 Graves disease mice models linear epitopes interferon-γ
  • 相关文献

参考文献1

二级参考文献10

  • 1顾雪疆,赵咏桔.Graves病的动物模型研究进展[J].国外医学(内分泌学分册),2005,25(5):344-346. 被引量:2
  • 2[2]Nagayama Y.Animal models of Graves hyperthyroidism[J].Endocr J,2005,52(4):385-394.
  • 3[3]Nagayama Y,Kita-Furuyama M,Ando T,et al.A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor[J].J Immunol,2002,168(6):2789-2794.
  • 4[4]Chen CR,Pichurin P,Nagayama Y,et al.The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim[J].J Clin Invest,2003,111(12):1897-1904.
  • 5[5]Tanaka K,Chazenbalk GD,McLachlan SM.Rapoport B:the shed thyrotropin receptor is primarily a carboxyl terminal truncated form of the A subunit,not the entire A subunit[J].Mol Cell Endocrinol,1999,150(1-2):113-119.
  • 6[6]Chazenbalk GD,Jaume JC,MeLachlan SM,et al.Engineering the human thyrotropin receptor ectodomain from a non secreted form to a secreted,highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera[J].J Biol Chetn,1997,272(30):18959-18965.
  • 7[7]Misrahi M,Milgrom E.Cleavage and shedding of the TSH reeeptor[J].Eur J Endoerinol,1997,137(6):599-602.
  • 8[8]ChenCR,PiehurinP,ChazenbalkGD,etal.Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease[J].Endocrinology,2004,145 (1):228-233.
  • 9[9]Schwarz-Lauer L,Pichurin PN,Chen CR,et al.The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors[J].Endocrinology,2003,144(5):1718-1725.
  • 10[10]Sehwarz-Lauer L,Chazenbalk GD,Mclaehlan SM,et al.Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor[J].Thyroid,2002,12(2):115-120.

共引文献4

同被引文献24

  • 1赵泽飞,王曙,崔九兰,顾雪疆,唐金凤,赵咏桔.表达TSHR-A亚单位的腺病毒免疫BALB/c雌性小鼠建立甲亢模型[J].现代免疫学,2008,28(3):229-232. 被引量:5
  • 2Bao X, Fang J, Li X. Structural characterization and immunomodu- lating activity of a complex gluean from spores of Ganoderma lucidum [J]. Biosci Biotechnol Biochem, 2001, 65(11): 2384-2391.
  • 3Lin YL, Lee SS, Hou SM, et al. Polysacchafide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper I immune response in BALB/c mice[J]. Mol Pharmacol, 2006, 70(2): 637-644.
  • 4Huang SQ, Li JW, Wang Z, et al. Optimization of alkaline extrac- tion of polysacchafides from Ganoderma lucidum and their effect on immune function in mice[J]. Molecules, 2010, 15(5) : 3694 - 3708.
  • 5Lai CY, Hung JT, Lin HH, et al. Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lueidum in vivo and in vitro[J]. Vaccine, 2010, 28(31 ) : 4945 -4954.
  • 6Chang YH, Yang JS, Yang JL, et al. Gandoderma lucidum extract promotes immune responses in normal BALB/c mice in vivo [ J ]. Vaccine. 2009. 23 (5) : 755 - 759.
  • 7Nagayama Y, Watanabe K, Niwa M, et al. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Thl immune suppression in a mouse model of Graves' hyperthyroidism [ J ]. J Immunol, 2004, 173(3): 2167-2173.
  • 8Saitoh O, Mizutori Y, Takamura N, et al. Adenovirus-mediated gene delivery of interleukin-lO, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice[J]. ClinExp Immunol, 2005, 141(3): 405 -411.
  • 9Kubota S, Amino N, Matsumoto Y, et al. Serial changes in liver function tests in patients with thyrotoxieosis induced by Graves' disease and painless thyroiditis[ J ]. Thyroid, 2008, 18 ( 3 ) : 283 - 287.
  • 10Zhang GL, Wang YH, Ni W, et al. Hepatoprotective role of Ganoderraa lucidura polysaccharide against BCG-indueed immurte liver injury in mice[J]. World J Gastroenterol, 2002, 8 (4): 728 - 733.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部